2012-10-03 - Female - 55 Years old
469618
| Adverse reaction report number | 469618 |
| Latest AER version number | 0 |
| Market authorization holder AER number | ALL1201204614 |
| Initial received date | 2012-10-03 |
| Latest received date | 2012-10-03 |
| Age | 55 Years |
| Gender | Female |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | MAH |
| Report outcome | Unknown |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR 30MG | Suspect | Oral | Attention deficit/hyperactivity disorder | ||||
| ADDERALL XR 30MG | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 30 Milligram | 1 every 1 Day(s) | Attention deficit/hyperactivity disorder | |
| ATIVAN | NOT SPECIFIED | Concomitant | |||||
| DEXEDRINE | NOT SPECIFIED | Concomitant | |||||
| WELLBUTRIN | TABLET (EXTENDED-RELEASE) | Concomitant |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Abdominal discomfort | |
| Anxiety | |
| Choking sensation | |
| Drug effect decreased | |
| Insomnia | |
| Irritability | |
| Myalgia | |
| Visual impairment | |